HAEHaemonetics Corporation
Price
+135%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
Quality mixed, nothing alarming, price roughly fair, growth fading, the market undecided.
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components.
In the company’s own words · 10-K filed May 20, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Haemonetics Corporation (HAE) reported revenue of $339M in Q1 2027 (quarter ended Jun 27, 2026), up 5.6% from the same quarter a year earlier. That came with a gross margin of 60% and net income of $33M (9.7% of revenue). For the full year FY2026, revenue was $1.33B (−2.0% year on year) and net income $97M. Its largest segment in Q1 2027 was Apheresis at $191M, 56% of the disclosed total, ahead of Med Surg at 44%. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 6, 2026Olga Guyette, Vice President-Investor Relations & Treasury.Earnings release · press release
- Jul 28, 2026On July 24, 2026, the Board of Directors of Haemonetics Corporation (the “Company”) elected Martin Madaus as a director of the Company, effective immediately.Director or officer change · Form 8-K
- Jun 5, 2026Olga Guyette, Vice President - Investor Relations & Treasury.Regulation FD disclosure · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Jun 2026 · $339.4MThe company’s own SEC segment disclosure.
- Apheresis$191.3M56%
- Med Surg$148.1M44%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.